A Phase I, Open-Label, Multi-Center Dose Finding Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of ATG-017 Monotherapy or Combination Therapy with Nivolumab in Patients with Advanced Solid Tumors and Hematological Malignancies

  • Voskoboynik, Mark (Primary Chief Investigator (PCI))
  • Tran, Ben (Chief Investigator (CI))
  • Gan, Hui K (Chief Investigator (CI))
  • Hawkins, Cheryl-Ann (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date23/07/20 → 31/12/23

Keywords

  • Medical oncology
  • Clinical trial